ASX: ALA Arovella Therapeutics Limited ACN 090 987 250 ASX Release 4 November 2026 CORRECTION TO PREVIOUS ANNOUNCEMENT RELATED TO CEO APPOINTMENT The previously lodged announcement stated the appointment of Nicole Van Der Weerden as Acting Chief Executive Officer effective today. The Company...